Data from past clinical trials can be used to draw new conclusions about diseases and treatments long after a trial is over.
But researchers rarely take advantage of this valuable resource even though access to a full data set, rather than published results alone, can help further research on how certain groups of people respond to a treatment or how people with an illness fare over time. In some cases, revisiting clinical trial data can also reveal problems with the initial analysis.
Read Full Article »